Moreover, two novel bona fide neuroblastoma oncogenes have been identified, ALK and LIN28B, that are sufficient to drive tumor formation when overexpressed in the neural crest or seem to increase the oncogenic potential of MYCN overexpression [5–8]. The gene discussed is LIN28B; the disease is neuroblastoma.